What's breaking now, across thousands of outlets.
After winning FDA approval at the end of last year, two nonprofits are now launching their rare immune disease gene therapy Waskyra with a list price of $3.25 million, they told Endpoints News. The nonprofits — ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Depression may be an overlooked factor in cancer outcomes, according to a large SEER-Medicare analysis of more than 265,000 adults with six common cancers.
GoFundMe says it was her identity, not her parents' story, that led to the fundraiser being pulled.
Data from an early trial showed the company’s “gamma delta” cell therapy surpassed benchmarks set by personalized CAR-T treatments tested in lupus.
Marie-Celestin Karondwa was attacked on Sunday after promoting measures to prevent spread of disease, his party says A senior member of the Democratic Republic of the Congo’s ruling party was beaten…
Marie-Celestin Karondwa was attacked on Sunday after promoting measures to prevent spread of disease, his party says A senior member of the Democratic Republic of the Congo’s ruling party was beaten…
